PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+6.2%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.34B
AUM Growth
+$2.34B
(+0.71%)
Cap. Flow
-$2.43M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
72.44%
Holding
37
New
–
Increased
22
Reduced
2
Closed
1
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$29.2M |
| 2 |
Insmed
INSM
|
$17M |
| 3 |
SHPG
Shire pic
SHPG
|
$8.28M |
| 4 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$6.69M |
| 5 |
CELG
Celgene Corp
CELG
|
$6.35M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$69.5M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$14.3M |
| 3 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$3.07M |
Sector Composition
| 1 | Healthcare | 92.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $392M | 16.76% | 1,346,660 -238,753 | -15% | -$69.5M |
|
|
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
| $209M | 8.93% | 3,955,660 +552,879 | +16% | +$29.2M |
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $206M | 8.82% | 2,545,482 +47,676 | +2% | +$3.87M |
|
4
United Therapeutics
UTHR
$13.8B
| $182M | 7.8% | 1,622,631 +16,381 | +1% | +$1.84M |
|
|
5
Insmed
INSM
$28.8B
| $161M | 6.89% | 7,159,590 +755,004 | +12% | +$17M |
|
|
SAGE
6
DELISTED
Sage Therapeutics
SAGE
| $132M | 5.64% | 818,331 +7,525 | +0.9% | +$1.21M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $127M | 5.41% | 1,135,845 +18,203 | +2% | +$2.03M |
|
|
EPZM
8
DELISTED
Epizyme, Inc
EPZM
| $122M | 5.23% | 6,895,075 +34,232 | +0.5% | +$608K |
|
9
Amicus Therapeutics
FOLD
$2.34B
| $92.5M | 3.95% | 6,147,829 +141,807 | +2% | +$2.13M |
|
|
IMMU
10
DELISTED
Immunomedics Inc
IMMU
| $70.1M | 3% | 4,796,008 +21,747 | +0.5% | +$318K |
|
11
Vanda Pharmaceuticals
VNDA
$279M
| $70M | 2.99% | 4,155,670 | – | – |
|
|
AMAG
12
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $67.3M | 2.88% | 3,340,806 -152,414 | -4% | -$3.07M |
|
13
Align Technology
ALGN
$10.3B
| $54.9M | 2.35% | 218,707 +6,200 | +3% | +$1.56M |
|
|
WMGI
14
DELISTED
Wright Medical Group Inc
WMGI
| $54.6M | 2.34% | 2,752,294 +16,001 | +0.6% | +$317K |
|
15
STAAR Surgical
STAA
$1.36B
| $52M | 2.22% | 3,515,385 +18,633 | +0.5% | +$276K |
|
16
Karyopharm Therapeutics
KPTI
$61.7M
| $49.4M | 2.11% | 3,679,978 +135,539 | +4% | +$1.82M |
|
|
AIMT
17
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $43.2M | 1.85% | 1,356,514 +210,095 | +18% | +$6.69M |
|
18
Prothena Corp
PRTA
$441M
| $40.4M | 1.73% | 1,101,338 +5,683 | +0.5% | +$209K |
|
19
Acadia Pharmaceuticals
ACAD
$4.38B
| $37.1M | 1.59% | 1,650,780 +9,750 | +0.6% | +$219K |
|
|
CELG
20
DELISTED
Celgene Corp
CELG
| $33.8M | 1.45% | 379,140 +71,200 | +23% | +$6.35M |
|
|
MNTA
21
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $33.2M | 1.42% | 1,830,435 +8,859 | +0.5% | +$161K |
|
|
SHPG
22
DELISTED
Shire pic
SHPG
| $28.6M | 1.22% | 191,200 +55,400 | +41% | +$8.28M |
|
|
ALDR
23
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $23.5M | 1% | 1,849,832 +9,586 | +0.5% | +$122K |
|
24
Rigel Pharmaceuticals
RIGL
$697M
| $14M | 0.6% | 3,966,087 +30,503 | +0.8% | +$108K |
|
25
Gilead Sciences
GILD
$140B
| $13.3M | 0.57% | 175,900 | – | – |
|